Skip to content

A randomized controlled trial to compare the efficacy of picosulfate sodium compound versus 2L polyethylene glycol electrolyte in bowel preparation for colonoscopy

A randomized controlled trial to compare the efficacy of picosulfate sodium compound versus 2L polyethylene glycol electrolyte in bowel preparation for colonoscopy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034695
Enrollment
Unknown
Registered
2020-07-15
Start date
2021-02-01
Completion date
Unknown
Last updated
2020-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel preparation

Interventions

experimental group:Picosulfate sodium compound
control group:polyethylene glycol electrolyte

Sponsors

Chengdu Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. Outpatient appointment for electronic colonoscopy; 3. Patients who agree to join the group and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with intestinal obstruction; 2. Patients with history of intestinal surgical resection; 3. Patients with untreated or uncontrolled hypertension; 4. Patients with serious systemic diseases, such as congestive heart failure, chronic renal insufficiency, liver cirrhosis, chronic obstructive pulmonary disease, malignant tumor, etc; 5. Patients with a history of acute myocardial infarction or unstable angina pectoris within 6 months before examination; 6. Patients with inflammatory bowel disease and megacolon bowel disease; 7. Patients who are allergic to any component of the drug; 8. Pregnant or lactating women; 9. Patients who were considered unsuitable by other researchers.

Design outcomes

Primary

MeasureTime frame
Intestinal Cleanliness (Boston Bowel Preparation Scale (BBPS));Adenoma and polyp detection rate;

Secondary

MeasureTime frame
Patients compliance;Adverse reaction;

Countries

China

Contacts

Public ContactLiu Liu

Chengdu Third People's Hospital

376334117@qq.com+86 18708146651

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026